TYRA (TYRA) Stock Price & Analysis
TYRA (TYRA) rose 0.00% to USD 30.63 as of July 25, 2026 at 03:06 UTC, according to Nexqual real-time market data.
TYRA last closed at USD 30.63; the session ranged USD 30.02–31.08 on volume of 627,486 shares. Market capitalization is —, with a 52-week range of USD 9.96–40.65 (NMS). Source: Nexqual, July 25, 2026 at 03:06 UTC.
Key Statistics (as of July 25, 2026 at 03:06 UTC)
| Price | USD 30.63 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 30.63 |
| Open | USD 30.63 |
| Day Range | USD 30.02 – 31.08 |
| 52-Week Range | USD 9.96 – 40.65 |
| Volume | 627,486 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (TYRA)
Nexqual's technical model rates TYRA "SELL" based on 1 bullish and 4 bearish signals across 125 daily candles, as of July 25, 2026 at 03:06 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 50.91 (neutral) |
| vs SMA50 | Below (USD 31.05) |
| MACD | 0.09 (positive) |
From TYRA's Latest SEC 10-K Filing (filed 2026-03-02)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| EWTX | Edgewise Therapeutics, Inc. | USD 40.84 | ▲ 6.55% |
| FDMT | 4D Molecular Therapeutics, Inc. | USD 10.07 | ▼ 8.12% |
| GLUE | Monte Rosa Therapeutics, Inc. | USD 22.78 | ▼ 4.25% |
| CGEM | Cullinan Therapeutics, Inc. | USD 17.1 | ▼ 3.12% |
| XLO | Xilio Therapeutics, Inc. | USD 8.65 | ▲ 2% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:06 UTC. This page is informational and not investment advice.